Voluntary Quality Assurance (VQA)™ Culture: Enhancing Analytical Excellence and CMC Readiness – by Judy Carmody, Ph.D.
The pharmaceutical industry faces unprecedented challenges in bringing life-saving medicines to market. According to the Tufts Center for the Study of Drug Development, the cost of bringing a new drug to market can exceed $2.8 billion when accounting for capital and trial failures. In this high-stakes environment, every stage of development must be optimized to…